Skip to main content
17/08/2022 - 09:13

CSL FY net profit dips to $A3.2bn

17/08/2022 - 09:13

Bookmark

Save articles for future reference.

Blood products and vaccines supplier CSL has reported a six per cent fall in annual profit and is tipping a slightly better earnings performance in 2022/23.

X

To read our articles you will need to either login or subscribe.